Genetics-Influenced Microbiome Composition Influences Wound Healing
The research showed that alternative TLN2 and ZNF521 genotypes explained significant inter-patient variation in relative abundance of two key pathogens. Wound diversity was lowest in Pseudomonas aeruginosa infected wounds, which had a significant negative linear relationship with healing rate.
Of Known Significance
An exclusive Clinical OMICs conversation with the director of Genomes2People, Robert Green, M.D., MPH.
CRISPR Comes of Age—As a Diagnostic
Hailed for its gene editing power, Sherlock Bioscience’s COVID-19 diagnostic is the first CRISPR technology to gain FDA approval.Hailed for its gene editing power, Sherlock Bioscience’s COVID-19 diagnostic is the first CRISPR technology to gain FDA approval.
Oncology Analytics’ Series B Yields $21M
The company will expand its health benefits management offerings, as well as make investments in data analytics and innovative health tech
Sherlock, binx health Partner on CRISPR-Based, Point-of-Care COVID-19 Test
Sherlock Biosciences and binx health said they plan to develop the world’s first rapid, point-of-care diagnostic test for COVID-19 using CRISPR technology.
Six Precision Medicine Companies Making Their Mark in 2020
This year’s list of innovative companies have all found, or developed, technology solutions that have allowed them to become innovators in their niche.
Genome Medical Raises $14M in Series B Financing
The company says it will use the funds to “expand its patient engagement and care navigation platform for cancer, reproductive health and pharmacogenomics to bring the benefits of genomic medicine to a wider U.S. population.”
Small Sequencer Developer GenapSys Completes $90M Series C Financing
GenapSys’ sequencing system is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment.
20 Molecular Diagnostics Companies to Watch
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
